Search Results

ML329 5 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

ML329 50 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

ML329 25 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

ML329 10 mg  | Purity Not Available

TargetMol

ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

More Information Supplier Page

AN2718 10 mg  | 98.89%

TargetMol

AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.

More Information Supplier Page

AN2718 25 mg  | 98.89%

TargetMol

AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro. It inhibits leucyl-tRN/A synthetase (LeuRS) from molds and yeasts (IC50s = 2 and 4.2 μM for A. fumigatus and C. albicans LeuRS, respectively), blocking protein synthesis.

More Information Supplier Page

Selamectin 10 mg  | Purity Not Available

TargetMol

Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.

More Information Supplier Page

Selamectin 100 mg  | Purity Not Available

TargetMol

Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.

More Information Supplier Page

R-IMPP 5 mg  | Purity Not Available

TargetMol

R-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.

More Information Supplier Page